Drug Type Small molecule drug |
Synonyms SCH 900978 |
Target |
Action antagonists |
Mechanism Neuropeptide receptor antagonists |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H23F6N5O2 |
InChIKeyACZWFJDLNLZWDP-ZGNKEGEESA-N |
CAS Registry873947-10-5 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chemotherapy-induced nausea and vomiting | Phase 2 | United States | - | |
| Nausea | Phase 2 | - | - | |
| Nausea | Phase 2 | - | - | |
| Vomiting | Phase 2 | - | - | |
| Vomiting | Phase 2 | - | - | |
| Cough | Phase 1 | United States | - | |
| Depressive Disorder, Major | Phase 1 | United States | - | |
| Urinary Bladder, Overactive | Phase 1 | United States | - |





